Arkolith/Insider Trading/IMPL/Form 4

Vivo Capital Surplus Fund VIII, L.P.

10% OwnerIMPEL NEUROPHARMA INC (IMPL) · full profile →Form 4 · filed Apr 29, 2021
Net Buying
Open-Market Buys
$8.6M
Open-Market Sells
$0
Net Open-Market Flow
$8.6M
Transactions
22
12 non-derivative · 10 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 27, 2021Conversion(C)710K——710K
Apr 27, 2021Conversion(C)98K——98K
Apr 27, 2021Conversion(C)475K——1.2M
Apr 27, 2021Conversion(C)66K——164K
Apr 27, 2021Conversion(C)440K——1.6M
Apr 27, 2021Conversion(C)61K——224K
Apr 27, 2021Conversion(C)315K——1.9M
Apr 27, 2021Conversion(C)44K——268K
Apr 27, 2021Conversion(C)89K$13.50$1.2M2.0M
Apr 27, 2021Conversion(C)12K$13.50$166K280K
Apr 27, 2021Buy(P)506K$15.00$7.6M2.5M
Apr 27, 2021Buy(P)69K$15.00$1.0M350K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 27, 2021Conversion(C)1.6M—$00
Apr 27, 2021Conversion(C)7.8M—$00
Apr 27, 2021Conversion(C)1.1M—$00
Apr 27, 2021Conversion(C)0—$00
Apr 27, 2021Conversion(C)0—$00
Apr 27, 2021Conversion(C)713K—$00
Apr 27, 2021Conversion(C)7.2M—$00
Apr 27, 2021Conversion(C)996K—$00
Apr 27, 2021Conversion(C)5.2M—$00
Apr 27, 2021Conversion(C)11.6M—$00

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-21-023652) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML